Log in for full access to this activity, if you are registered.

Registration Options

Activity Dates: 05/16/2019 - 04/10/2022

Target Audience

This course is designed for pharmacists, nurse practitioners or other health care professionals involved in the comprehensive medication management of psychiatric and/or neurological patients.

Session Summary

Within the past several decades, the United States and other countries around the world have seen an increased prevalence of long-term antidepressant use. While evidence for the long-term use of antidepressants exists, particularly in relation to relapse prevention, there is still a lack of robust data regarding overall long-term use, the optimal length of antidepressant treatment, and particular patient factors that may influence the benefits or risks of continued, long-term use of antidepressant medications. Psychiatric pharmacists are well-suited to help treatment teams identify the benefits and risks for long-term use of antidepressant medications and make patient-centered decisions about continued antidepressant use.

This program will provide participants with information regarding the current trends in the long-term use of antidepressants, the benefits and risks of continued long-term use, and the factors related to making the most patient-centered decisions about continued, long-term use of antidepressant medications.

Course Requirements

You will proceed through the following steps to satisfactorily complete this course:

  • Complete the pre-test before starting the activity. (login first)
  • Review the full content of the activity and reflect upon its teachings.
  • Complete the post-test at the end of the activity no later than the closing activity date. (login first)
  • Complete the evaluation at the end of the activity. (login first)
  • If necessary, complete the post-test retest no later than the closing activity date. (login first)
  • Receive a passing grade (70%).
  • Provide the necessary details in your profile to ensure correct reporting by CPNP to CPE Monitor. (login first)

Participants in this course must complete an examination and achieve a score of 70% or greater. Successful completion of the course also requires the completion of a course evaluation. Upon successful completion, ACPE credit is reported immediately to CPE Monitor although transcripts can be retrieved by participants online at http://cpnp.org/mycpnp/transcript/acpe.

Faculty Information and Disclosures

Learning Objectives

  1. Identify guideline recommendations for continuance and maintenance of antidepressant drug therapy after a first depressive episode.
  2. Outline the potential benefits of long-term antidepressant medication management.
  3. Define the potential hazards in long-term antidepressant use.
  4. Identify key patient-specific factors that may warrant continuation of long-term antidepressant use vs. de-prescribing of antidepressants.

Continuing Education Credit and Disclosures

Activity Dates: 05/16/2019 - 04/10/2022
ACPE Contact Hours: 1.0
ACPE Number: 0284-0000-19-033-H01-P (Knowledge)
Nursing Credit Reminder: Note that ACPE credit is accepted for certification renewal.

ACPEThe College of Psychiatric and Neurologic Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This course provides 1.0 contact hour of knowledge-based continuing education credit from CPNP approved programming.

Grant Support

Supported by an educational grant from Takeda Pharmaceuticals U.S.A., Inc. and Lundbeck